Report cover image

Cell-Free DNA (cfDNA): Market Size and Share Analysis (Consumables, Systems, Services)

Publisher Kalorama Information
Published Apr 12, 2017
Length 178 Pages
SKU # KLI15188961

Description

 Cell-Free DNA (cfDNA) Markets details the market opportunity for cfDNA analysis instruments, consumables, kits, and related software. The report provides complete market information, including current market estimates and forecasts to 2021, as well as:
  • Growth Rate for cfDNA Market, 2016-2021
  • cfDNA Clinical Diagnostics Market, 2016-2021
  • cfDNA Clinical Diagnostics Market Growth Rate, 2016-2021
  • cfDNA Market by Region, 2015 (N. America, Europe, Asia-Pacific & ROW)
  • cfDNA Instruments and Consumables Revenues by Product Type, 2016 (Consumables, Systems, Services)
  • Market Share by Company of the cfDNA Analysis Instruments, Consumables, and Software Market, 2016
The report provides information on cfDNA analysis products, commenting not only on reagents, consumables, kits, systems, software, and services, but also on oncology cfDNA products, cfDNA transplantation diagnostics, and other products employing cfDNA.

In the cfDNA market there are many technical challenges to overcome, along with a range of competitive, regulatory, and IP issues. Cancer is a dynamic and defiant disease. While NIPT is a proven application, oncology will require much more difficult work and is more uncertain. The variety of potential issues and threats in the market are covered in the challenges and strategic recommendations chapter of the report. The competitive situation, deals, and litigation are covered in respective chapters as well.

Cell-Free DNA (cfDNA) Markets covers not just the dynamics of the market but also its competitive landscape. For example, several companies are licensing their technologies or offering services. The report profiles those companies competing in the cfDNA instruments and consumables market, including:
  • Agilent Technologies
  • Bio-Rad
  • F. Hoffmann-La Roche AG
  • Fluidigm
  • Illumina
  • Qiagen
  • RainDance Technologies
  • Thermo Fisher Scientific
The report was produced through a combination of primary research, secondary research, and internal databases, including SEC filings, product literature, corporate websites, conferences, journals, and trade publications.

Table of Contents

178 Pages
    • NIPT, Oncology Leading Market Forward
    • Sensitivity Benefits of dPCR, qPCR, NGS
    • Challenges, Biological and Technologies Limitations
    • Scope and Methodology
    • NIPT Companies, Others Shifting Strategies to Cancer
    • Expanding Clinical Adoption Sustains High Growth
    • Government Initiatives -- Cancer Moonshot, Blood Profiling Atlas
    • Mergers, Acquisitions, Equity Investments Increasing
    • China Becoming Major Player in Market
    • Personalized, Proactive Medicine Gaining Momentum
    • Expected Sequencer Platforms Stalled or Cancelled
    • Significant Efforts in Automation, Miniaturization
    • Regulatory Situation Unclear But Evolving Somewhat
    • cfDNA Reagents, Consumables, and Kits
    • cfDNA Systems and Software
    • cfDNA NIPT Products and Services
    • cfDNA in Oncology, Transplantation and Other Diseases
    • cfDNA Other Products
    • Recent Product/ Service Introductions
    • Revenues Forecast
    • Market Size and Forecast
    • cfDNA Clinical Diagnostics Market
    • cfDNA Market by Region
    • Revenues by Product Type
    • Illumina Sequencing Revenues as Indicator
    • Introduction
    • cfDNA Instruments and Consumables Market Shares
    • Sequenom, Several NIPT Companies Fighting
    • Ariosa Diagnostics (Roche) Files Suit Against Sequenom
    • Natera Sues Sequenom; Sequenom Sues Natera
    • Verinata Health and Stanford File Against Sequenom
    • Verinata Health Against Ariosa and LabCorp
    • Illumina Sues Ariosa Diagnostics for NIPT Test
    • Illumina Sues Premaitha Health for NIPT Test
    • Illumina Sues Premaitha and Ariosa Partners
    • Sequenom and Illumina Settle and Pool Patents
    • Sequenom Petitions Supreme Court
    • Illumina Sues Qiagen for GeneReader System
    • llumina's Conflicts with Oxford Nanopore
    • Enzo Biochem Brings Suit Against Numerous Companies
    • 454 (Roche) Sues Ion Torrent (Thermo Fisher)
    • RainDance Technologies Sues 10X Genomics
    • 10X Genomics' Dispute with Bio-Rad
    • Sequenom Shareholder Sues Over Price "Capping"
    • Helicos' Patent Infringement Suit Against PacBio, Life Technologies, and Illumina
    • Illumina's Two Lawsuits Against Complete Genomics for Infringement
    • Life Technologies and Illumina Dispute Over Amplification on Solid Surfaces
    • Enzo Biochem Disputes Sequencing Patents
    • LabCorp's Esoterix Sues Life Technologies
    • Genetic Technologies Sues Several Firms for Infringement of Haplotype Determination Technique
    • The Significant Collaborations
    • Agilent Technologies
    • Bio-Rad
    • F. Hoffmann-La Roche AG
    • Fluidigm
    • Illumina
    • Qiagen
    • RainDance Technologies
    • Thermo Fisher Scientific
    • Challenges
    • Strategic Recommendations

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us